RECENT BYLINES
Look before you leap: Why we shouldn’t jump to conclusions about supplement studies
by Andrea Wong, Ph.D., NutraIngredients-USA, February 2025
2025 Challenges & Opportunities: A Dickens of a Time
by Steve Mister, WholeFoods Magazine, January 2025
CRN: Goldilocks and the regulatory bear: Avoiding the too-hot, too-cold pitfalls of supplement rules
by Steve Mister, NutraIngredients-USA, December 2024
Reprinted with permission, courtesy of NutraIngredients-USA.
Making the harder choice: CRN’s self-regulatory initiatives
by Andrea Wong, Ph.D., NutraIngredients-USA, December 2024
The Importance of Being Responsible — Let Me Count the Ways ...
by Steve Mister, Nutraceuticals World, September 2024
Chevron deference and drug preclusion: Another way forward for dietary supplements
by Steve Mister, Natural Products Insider, August 2024
ACI-CRN conference: Megan Olsen’s takeaways
By Megan Olsen, Natural Products Insider, July 2024
DNA study behind 2015 herbs and botanicals investigation retracted
by Steve Mister, New Hope Network, July 2024
Misguided Legislation: Supplement Laws Stifle Free Speech and Miss the Mark on Eating Disorders
by Steve Mister, Drug Store News, June 2024
Military supplement users: Beware of tigers masquerading as dogs
by Steve Mister, and Andrea Lindsey, Military Times, May 2024
FDA's latest NDI guidance falls short of goal
by Steve Mister, Nutrition Business Journal, April 2024
Reprinted with permission, courtesy of Nutrition Business Journal. More information: store.newhope.com/pages/nbj-subscriptions
Opinion: Mandatory Listing: Facts, Fiction and Conspiracies
by Steve Mister, NutraIngredients-USA, March 2024
Bad company: How the industry can save itself–and consumers–from fake supplements
by Steve Mister, Natural Products Insider, January 2024
2024 Call to Action for the Natural Products Industry
by Steve Mister, Whole Foods Magazine, December 2023
Where Advocacy Meets Diplomacy: 2023 Demanded a Full Toolbox
by Steve Mister, NutraIngredients-USA, December 2023
Apple Picking and Drug Preclusion: Let’s Make it a Fair Contest
by Steve Mister, NutraIngredients-USA, November 2023
Consumers Are Tired of an ‘Impotent’ FDA
by Steve Mister, Nutrition Industry Executive, October 2023
CRN at 50: Bringing exceptional value to the bottom line for members willing to engage
by Luke Huber and Carl Hyland, CRN, September 2023
Melatonin gummies are safe, just ask America
by Steve Mister, Drug Store News, May 2023
Council for Responsible Nutrition outlines policy priorities for 2023
by Steve Mister, Natural Products Insider, March 2023
Innovation Slowed During the Pandemic: A Wharton Study Tells Us How to Fix It.
by Carl Hyland, Nutrition Industry Executive, January 2023
‘Responsible’ has been our middle name for 50 years
by Steve Mister, NutraIngredients-USA, December 2022
Between Safe and Unsafe Is There an Optimal Middle Ground?
by Jim Griffiths, Ph.D., Nutrition Industry Executive, December 2022
Browse a selection of additional articles by CRN staff experts below. Jump to topics:
BUSINESS | REGULATION | CBD | SPORTS NUTRITION
SCIENTIFIC RESEARCH | RETAIL RELATIONS
DEI & HR | 2021 | 2020
BUSINESS
Innovation Slowed During the Pandemic: A Wharton Study Tells Us How to Fix It.
by Carl Hyland, Nutrition Industry Executive, January 2023
8 Reasons Why Early-stage Companies Should Join Industry Trade Associations
by Steve Mister and Carl Hyland, Nutrition Industry Executive, September 2022
REGULATION
Between Safe and Unsafe Is There an Optimal Middle Ground?
by Jim Griffiths, Ph.D., Nutrition Industry Executive, December 2022
Drug preclusion and public health: The case for a narrow interpretation of ‘article’
by Megan Olsen and Daniel Garza, RAPS, November 2022
Supplement Manufacturers Must Be at the Codex Table
by Jim Griffiths, Ph.D., Nutrition Industry Executive, August 2022
Furor about new prohibited act is much ado about nothing
by Miriam Guggenheim and Steve Mister, NutraIngredients, July 2022
Institutionalizing Visibility and Enforcement—The Dietary Supplement Listing Act of 2022
by Steve Mister, Healthcare Business Today, July 2022
Op-Ed: 80% of Americans take dietary supplements. Better oversight and safety are musts
by Steve Mister, Indy Star, May 2022
Mandatory Product Listing: It Won’t 'Wash the Windows' Either!
by Steve Mister, NutraIngredients-USA, May 2022
Ignore the Red Herrings: Myths & Facts about Mandatory Product Listing
by Steve Mister, Nutraceuticals World, May 2022
The Industry’s Responsibility in an Era of Regulatory Uncertainty
by Steve Mister, Nutrition Industry Executive, January 2022
Amending DSHEA: A kid in a candy store or a bull in a china shop?
by Steve Mister in Natural Products Insider, April 2021
Supreme Court holds that FTC must complete administrative process before obtaining monetary relief
co-authored by Megan Olsen in Washington Legal Foundation, April 2021
CRN State Regulation Update
by Amanda Darlington in Nutrition Industry Executive, Jan. 2021
Stop the sale of bogus supplements as a cure or treatment for COVID-19
by Julia Gustafson with Liz Richardson of The Pew Charitable Trusts in The Hill, Sept. 2020
New Dietary Ingredients: Will FDA protect consumers from pirates and piggybackers?
by Steve Mister in NutraIngredients-USA, August 2020
A Mandatory Dietary Supplement Registry: Transparency as ‘disinfectant’
by Steve Mister in RAPS Regulatory Focus, June 2020
Integrating master files in the NDI notification process to facilitate innovation in dietary supplements
by Haiuyen Nguyen in RAPS Regulatory Focus, June 2020
NYAG: Five Years Later, What Did We Learn?
by Steve Mister in Nutrition Industry Executive, April 2020
What everyone needs to know about supplement regulation
by Andrea Wong in Natural Products Insider, March 2020
Supplement industry must self-police as demand soars, FDA retreats
by Steve Mister in New Hope, April 2020
Mandatory Product Listing: Beneficial, or Burdensome?
by Steve Mister in WholeFoods Magazine, Feb. 2020
Dietary Supplements and Public Safety: A Defense of DSHEA’s 'Three-Legged Stool'
by Steve Mister in RAPS Regulatory Focus, June 2019
SPORTS NUTRITION
Sports Supplements Are Under Attack—Here's How We're Fighting Back
by Luke Huber, ND, MBA and William Dumais, Nutrition Industry Executive, March 2022
Sports Nutrition Supplements As Convenient Scapegoats
by Steve Mister and Amanda Darlington in Nutrition Industry Executive, July 2020
Sports nutrition category adapts to changing consumer practices during COVID-19
Natural Products Insider, by CRN's Luke Huber, ND, MBA, and Jim Komorowski, MS, CNS, chief science officer of CRN member company JDS Therapeutics and chair of CRN's Sports Nutrition Working Group (SNWG), June 2020
Sports nutrition: Challenges and opportunities amid COVID-19
by Luke Huber, ND, MBA, in Natural Products Insider, Aug. 2020
CBD — See more thought leadership from CRN on CBD
Don't Sell Out DSHEA for CBD
by Steve Mister, NutraIngredients-USA, August 2021
If you repeat something often enough…even with CBD
by Steve Mister in Natural Products Insider, April 2021
CRN Files Citizen Petition Calling on FDA to Regulate CBD as a Legal Dietary Supplement
Press Release | Citizen Petition | CRN's Supplement Advocacy Send-In June 2020
More from this story, for CRN members, from the CRN Daily Supplement:
- Over 20 million Americans report using CBD supplements—12% of supplement users reported taking CBD
- Collaborative for CBD Science and Safety launches, CRN among steering committee members
- CRN Calls on Congress to Declare CBD a Lawful Dietary Ingredient—FDA Continues Inaction
Hey, FDA, can you show a little CBD discretion?
by Steve Mister in Natural Products Insider, Feb. 2020
5 (actually, 10) things that should concern us about CBD
by Steve Mister in New Hope, Dec. 2019
Will CBD Become a Shakespearean Tragedy?
by Steve Mister in Nutrition Industry Executive, Jan. 2019
Science, CBD and the prisoner's dilemma
by Steve Mister in Natural Products Insider, Feb. 2019
CBD and the 2018 Farm Bill—the legal status of CBD supplements
by Megan Olsen Natural Products Insider, Feb. 2019
SCIENTIFIC RESEARCH
Optimizing Healthspan: Innovative Approaches to Health Promotion
by Jim Griffiths, Ph.D., Nutrition Industry Executive, August 2021
Probiotics: What’s Inside Is Alive
by Andrea Wong, Ph.D., in Nutrition Industry Executive, May 2021
The supportive role supplements can play for sleep and mental health
by Andrea Wong, Ph.D., in Natural Products Insider, Dec. 2020
Dietary supplement delivery forms matter
by Andrea Wong, Ph.D., in Natural Products Insider, Nov. 2020
Healthy aging: Quest for a healthy, not just long, life
by Jim Griffiths in Natural Products Insider, April 2020
Is Science For Sale? CRN expert reacts to recent attack on industry
by Andrea Wong, Ph.D., in NutraIngredients, Jan. 2020
Dietary Supplement Clinical Research in the Age of COVID-19: Challenges & Opportunities
by Luke Huber, ND, MBA, in Nutraceuticals World, Sep. 2020
RETAIL RELATIONS
Enhancing consumer confidence and supplement access through harmonized retail standards
by Megan Olsen, in RAPS Regulatory Focus, June 2021
Examining retailer verification measures for dietary supplements
by Megan Olsen in Natural Products Insider, Feb. 2021
CRN: Quality Is the Price of Entry—Not a Point of Difference
by Steve Mister in NutraIngredients-USA, Dec. 2020
2020: The Year We Woke Up to Our Interdependence With Retailers
by Steve Mister in Nutrition Industry Executive, Dec. 2020
Educating the public about probiotics—the valuable role retailers play
by Andrea Wong, Ph.D. in New Hope, Oct. 2020
DIVERSITY, EQUITY & INCLUSION and HUMAN RESOURCES
Racial injustice: It’s time for more than introspection
by Steve Mister in Natural Products Insider, June 2020
Diversity Has Always Been Our Strength—On Racial Diversity, We Can Do Better—It Starts With Recognizing That Fact
by Carl Hyland in Nutrition Industry Executive, October 2020
2021
Industry Needs Consensus in 2022, CRN Says
by Steve Mister, NutraIngredients-USA, December 2021
Healthy Innovation Must be Nourished
by Steve Mister, Nutrition Industry Executive, December 2021
Leadership demands empathy, agility and resilience
by Steve Mister, Natural Products Insider, November 2021
Companies Serving Health Care Practitioners Need Specific Support
by Luke Huber, ND, MBA, Nutrition Industry Executive, October 2021
Vitamin D & Me!
by Luke Huber, ND, MBA and Susan Hewlings, PhD, of Nutrasource, Nutrition Industry Executive, August 2021
Don't Sell Out DSHEA for CBD
by Steve Mister, NutraIngredients-USA, August 2021
The dietary supplement industry’s drug preclusion predicament
by Steve Mister, Natural Products Insider, August 2021
Optimizing Healthspan: Innovative Approaches to Health Promotion
by Jim Griffiths, Ph.D., Nutrition Industry Executive, August 2021
Don’t let your supplement brand get knocked out by knockoffs
by Jim Griffiths, Ph.D., Natural Products Insider, June 2021
Enhancing consumer confidence and supplement access through harmonized retail standards
by Megan Olsen, in RAPS Regulatory Focus, June 2021
Best practices and education for probiotics amid regulatory uncertainty
by Andrea Wong, Ph.D., in RAPS Regulatory Focus, June 2021
Probiotics: What’s Inside Is Alive
by Andrea Wong, Ph.D., in Nutrition Industry Executive, May 2021
Supreme Court holds that FTC must complete administrative process before obtaining monetary relief
co-authored by Megan Olsen in Washington Legal Foundation, April 2021
Dietary Supplements Attract Private Equity; A Good Trade Association Should, Too
by Steve Mister and Carl Hyland in Nutrition Industry Executive, April 2021
If you repeat something often enough…even with CBD
by Steve Mister in Natural Products Insider, April 2021
Participation in the Supplement OWL Critical for Responsible Industry
by Luke Huber, ND, MBA, in Nutrition Industry Executive, March 2021
Examining retailer verification measures for dietary supplements
by Megan Olsen in Natural Products Insider, Feb. 2021
2020
2020 and Optimism Comes to Mind
by Steve Mister in Nutrition Industry Executive, Jan. 2020
The legacy of 2019: CBD, mandatory listing and discord
by Steve Mister in NutraIngredients, Dec. 2019